Table 2.
Over time development and controversies in definition of metabolically healthy/unhealthy overweight/obese
Wildman et al. [90] | BioSHaRE-EU Healthy Obese Project [56] | Lavie et al. [91] | |
---|---|---|---|
Less strict | Stricter | ||
IFG/IGT/T2DM | FPG > 126 mg/dL | FPG > 110 mg/dL | FPG > 100 mg/dL |
BP ≥ 130/85 mmHg | BP > 140/90 mmHg | BP > 130/85 mmHg | BP > 130/85 mmHg |
TAG > 150 mg/dL | |||
HDL < 40 (W) or < 35 (M) mg/dL | |||
WC > 88 cm (W), > 102 cm (M) | |||
HOMA-IR [92] | |||
hsCRP | |||
BMI > 25 or > 30 kg/m [2] | None (MHO) or ≥ 1 (MUO) | 0–1 (MHO) or ≥ 1 (MUO) |
IFG impaired fasting glucose, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitus, BP blood pressure, TAG triglycerides, HDL high-density lipoprotein, WC waist circumference, BMI body mass index, CAD coronary artery disease, HOMA-IR homeostasis model assessment for insulin resistance, hsCRP high-sensitivity C-reactive protein, MHO metabolically healthy overweight/obese, MUO metabolically unhealthy overweight/obese